导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -43.34% | 1049/1050 |
| 近一周 | 4.67% | 18/1104 |
| 近一月 | -4.35% | 703/1103 |
| 近一季 | -36.36% | 1091/1092 |
| 近半年 | -46.96% | 1069/1070 |
| 近一年 | -38.18% | 1015/1018 |
| 近两年 | 28.11% | 701/926 |
| 近三年 | 5.56% | 624/834 |
| 成立以来 | 229.65% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.39% 518/1070 |
-14.40% 1005/1101 |
- - |
- - |
| 2025 | 57.57% 127/1065 |
-2.23% 921/1014 |
-6.23% 984/1038 |
61.36% 35/1050 |
6.51% 93/1065 |
| 2024 | 17.33% 128/1011 |
-14.86% 914/960 |
11.67% 7/983 |
6.64% 834/991 |
15.73% 28/1011 |
| 2023 | -0.17% 101/952 |
12.39% 73/880 |
-2.97% 373/895 |
-11.48% 651/915 |
3.41% 39/952 |
| 2022 | -32.63% 674/867 |
-23.13% 672/773 |
11.88% 195/806 |
-10.18% 249/845 |
-12.78% 819/867 |
| 2021 | -6.57% 441/740 |
-2.23% 231/580 |
10.24% 350/659 |
-6.80% 408/704 |
-7.00% 625/740 |
| 2020 | 60.62% 191/554 |
6.07% 62/419 |
26.03% 182/466 |
6.99% 320/517 |
12.30% 277/554 |
| 2019 | 58.61% 87/410 |
37.25% 102/1149 |
-4.42% 672/1231 |
8.36% 142/390 |
11.58% 120/410 |
| 2018 | -47.95% 283/349 |
- - |
- - |
- - |
-18.95% 982/1080 |
| 2017 | 47.09% 7/285 |
- - |
- - |
- - |
- - |
| 2016 | -0.88% 30/205 |
- - |
- - |
- - |
- - |
| 2015 | 17.51% 55/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国泰金鑫股票A VS. 东吴新产业精选股票A(580008) |